Medsir

This trial is testing a new combination of three drugs as the first treatment for people with advanced triple-negative breast cancer that tests positive for a marker called PD-L1. The goal is to see if the combination is safe and can shrink tumors and control the cancer. It will …

This study is testing whether combining two drugs, camizestrant and ribociclib, can better control advanced hormone-positive breast cancer. It will involve about 150 adults whose cancer has progressed despite at least 5 years of prior hormone-blocking therapy. The main goal is to…

This study is testing a new type of 'theranostic' drug that first acts like a medical dye to locate cancer in the brain and then delivers targeted radiation to treat it. It is for adults with solid tumors, including HER2-positive breast cancer, that have spread to the brain and a…

This study is testing whether adding a new immunotherapy drug, bexmarilimab, to a standard chemotherapy (doxorubicin) is safe and more effective for people with metastatic soft-tissue sarcoma. The main goals are to find the safest dose of the new combination and to see if it can …

This study aims to see if giving atropine, a common medication, can prevent severe diarrhea in people with advanced breast cancer who are being treated with the drug sacituzumab govitecan. It will enroll about 30 adults with specific types of advanced breast cancer that has progr…